Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

KIR2DL1/CD158a Mouse anti-Human, Alexa Fluor™ 594, Clone: MM0439-8J29, Novus Biologicals™

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP211759AF594

Catalog No. NP21179A94


Add to cart

Description

Description

KIR2DL1/CD158a Monoclonal specifically detects KIR2DL1/CD158a in Human samples. It is validated for Flow Cytometry.
Specifications

Specifications

KIR2DL1/CD158a
Monoclonal
Alexa Fluor 594
50 mM sodium borate with 0.05% sodium azide
KIR2DL1
Human recombinant KIR2DL1/CD158a
Immunology, Innate Immunity, Signal Transduction
3802
Human
IgG1
Flow Cytometry
MM0439-8J29
Flow Cytometry
CD158 antigen-like family member A, CD158a antigen, CD158Ankat1, cl-42, killer cell immunoglobulin-like receptor 2DL1, killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1, killer Ig receptor, killer inhibitory receptor 2-2-1, KIR221, MHC class I NK cell receptor, Natural killer-associated transcript 1, NKAT, NKAT-1, NKAT1KIR-K64, p58 killer cell inhibitory receptor KIR-K64, p58 natural killer cell receptor clones CL-42/47.11, p58 NK cell inhibitory receptor NKR-K6,47.11, p58 NK receptor CL-42/47.11, p58.1, p58.1 MHC class-I-specific NK receptor
Mouse
0.1 mL
Primary
This antibody only detects KIR2DL1 there is no cross reactivity with other KIRs.
Store at 4°C in the dark.
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit